kopp drug classifications

Course Overview and Laboratory Experience

  • Challenges Ahead

    • Upcoming lab sessions will focus on practical applications of respiratory drug classifications.

    • Transitioning from theory-based content to hands-on experience with equipment.

    • Emphasis on understanding how different respiratory drugs are classified and their applications.

  • Semester Expectations

    • This portion of the semester is less intense than previous sessions, but still requires retention of critical formulas and concepts.

    • Key concepts will remain relevant for future classes, especially regarding respiratory therapy and patient assessment.

Clinical Skills Development

  • Importance of Practice

    • Consistent practice is essential for mastering key clinical skills, such as pulse taking.

    • Encourage students to take pulse readings manually.

    • Use monitors as a supplementary tool but develop a tactile understanding of pulse.

  • Respiratory Sound Assessment

    • Students need to refine their technique for listening to breath sounds.

    • Be aware of proper placement of the stethoscope, avoiding areas above the scapula or over the kidneys.

    • Coordinate timing of breath sounds; listen closely during both inhalation and exhalation.

      • Significant sounds such as wheezing are predominantly heard during expiration.

Clinical Responsibilities and Preparedness

  • Interactions with Patients

    • Students are advised to communicate clearly with patients.

    • Avoid unnecessary commands during assessments (e.g., continuous prompts to breathe in/out).

    • Give patients time to follow instructions and respond naturally.

  • Clinical Assignments in Hospitals

    • Students will be assigned to experienced respiratory therapists for hands-on learning opportunities.

    • Importance of documentation in clinical settings:

    • Bring log sheets and evaluation forms for progress tracking.

    • Clarify roles and responsibilities when assigned tasks in team settings.

Clinical Logistics and Evaluations

  • Preparation for Clinical Experiences

    • Students should familiarize themselves with clinical settings and navigate hospital processes (like parking).

    • Visit facilities ahead of time if possible to ease first-day anxiety.

  • Clinical Evaluation Procedures

    • Evaluations will be completed post-shift to get feedback on performance.

    • Prepare for constructive criticism and note areas for improvement.

Future Scheduling and Breaks

  • Academic Calendar Overview

    • Classes continue until early December, with exams scheduled for December 8 and December 12.

    • Exam review will occur on December 5, allowing time to clarify any outstanding topics.

  • Break Periods

    • Thanksgiving break schedule is confirmed.

    • Significant break periods are noted, including Spring break (second week of March) and summer break starting in late May.

Introduction to Pharmacology

  • Introduction to Respiratory Pharmacology

    • Overview of pharmacology, particularly in respiratory therapy.

    • Focus on how drugs interact with the body and pharmacokinetics and pharmacodynamics definitions:

    • Pharmacokinetics: How the body processes a drug (absorption, distribution, metabolism, excretion).

    • Pharmacodynamics: How the drug affects the body.

  • The ADME Framework

    • Drug movement through the body consists of:

    • Absorption

    • Distribution

    • Metabolism

    • Excretion

Routes of Drug Administration

  • Forms and Routes

    • Predominantly aerosolized drugs used in respiratory therapy due to rapid onset and localized effect.

    • Other routes include:

    • Oral medications: Slower onset due to digestion.

    • Intravenous (IV): Fastest systemic effect, primarily for emergencies.

    • Intramuscular/Subcutaneous: Used less frequently in respiratory therapy.

    • Endotracheal (ET) administration: Reserved for critical situations without IV access.

Respiratory Drug Classifications

1. Bronchodilators

  • Beta-2 Agonists: Most commonly used bronchodilators (e.g., Albuterol, Levabuterol).

    • Albuterol (Ventolin): Short-acting beta-agonist.

    • Levabuterol (Xopenex): Similar to albuterol but with fewer side effects, such as tachycardia.

    • Salmeterol: Long-acting beta agonist for maintenance therapy.

2. Anticholinergics

  • Block acetylcholine receptors to prevent bronchoconstriction (e.g., Ipratropium, Tiotropium).

    • Ipratropium (Atrovent): Often combined with beta-agonists.

    • Tiotropium (Spiriva): Used primarily in COPD management.

3. Corticosteroids

  • Anti-inflammatory medications used to prevent respiratory inflammation (e.g., Budesonide, Fluticasone).

    • Administered primarily via inhalation for minimal side effects.

    • Requires rinsing the mouth after use to prevent oral infections.

Patient Management and Pharmacology

  • Drug Monitoring

    • Continuously monitor patients for side effects like tachycardia when using beta-agonists.

    • Importance of knowing peak flow measurements for patients with asthma.

    • Combine treatments wisely (e.g., beta-agonists with corticosteroids) for comprehensive management.

  • Specific Situations in Practice

    • Continuous albuterol for patients in status asthmaticus or other severe respiratory conditions.

    • Importance of electrolyte monitoring, particularly potassium, when administering high doses of beta-agonists.

Ethical Considerations in Medicine

  • Importance of ethical practice in healthcare settings.

    • Recognize the responsibilities of healthcare providers in protecting patient safety.

    • Discuss potential misuse or abuse of drugs, emphasizing the serious consequences.

  • Patient Interactions

    • Awareness of emotional impacts of medical decisions on patients and families.

    • Recognize the importance of clear communication about resuscitation efforts and treatment expectations.